This inventor holds 2 USPTO granted patents. Top assignees: Astellas Pharma Gmbh, Yamanouchi Pharmaceutical Company Ltd.. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2004-2007
Title: The Innovative Journey of Miki Kobayashi
Introduction
Miki Kobayashi is a prominent inventor based in Tsukuba, Japan. With a strong focus on pharmaceutical innovations, she has made significant contributions through her patents. Her work emphasizes the importance of developing effective treatments for respiratory diseases.
Latest Patents
Miki Kobayashi holds two patents, one of which is a remarkable innovation involving a compound known as Phenylpyridinecarbonylpiperazinederivative. This invention pertains to a compound represented by a specific formula that showcases type 4 phosphodiesterase inhibitory action. The derivatives, characterized by specific substituents, have proven to be useful as drugs, particularly as preventive or therapeutic agents for respiratory diseases linked to PDE IV. This outstanding work highlights the potential of her inventions to contribute significantly to the pharmaceutical industry.
Career Highlights
Throughout her career, Miki has been associated with notable companies in the pharmaceutical sector, including Yamanouchi Pharmaceutical Company Ltd. and Astellas Pharma GmbH. Her tenure in these organizations has allowed her to develop expertise in drug formulation and innovation, leading to her successful patent applications.
Collaborations
Miki has collaborated with talented individuals such as Masahiro Iwata and Noriyuki Kawano. Her collaborative efforts have contributed to the advancement of research and the development of new pharmaceutical compounds aimed at improving health outcomes.
Conclusion
Miki Kobayashi's contributions to the field of pharmacology and her innovative spirit have made her a key figure in the development of new treatments for respiratory diseases. Her patents reflect a deep commitment to enhancing human health through science and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile